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Aims Hybrid imaging provides a non-invasive assessment of coronary anatomy and myocardial perfusion. We sought to
evaluate the added clinical value of hybrid imaging in a multi-centre multi-vendor setting.
Methods and
results
Fourteen centres enrolled 252 patients with stable angina and intermediate (20-90%) pre-test likelihood of coronary ar-
tery disease (CAD) who underwent myocardial perfusion scintigraphy (MPS), CT coronary angiography (CTCA), and
quantitative coronary angiography (QCA) with fractional flow reserve (FFR). Hybrid MPS/CTCA images were obtained
by 3D image fusion. Blinded core-lab analyses were performed for CTCA, MPS, QCA and hybrid datasets. Hemodynam-
ically significant CAD was ruled-in non-invasively in the presence of a matched finding (myocardial perfusion defect co-
localized with stenosed coronary artery) and ruled-out with normal findings (both CTCA and MPS normal). Overall
prevalence of significant CAD on QCA (.70% stenosis or 30-70% with FFR≤0.80) was 37%. Of 1004 pathological myo-
cardial segments on MPS, 246 (25%) were reclassified from their standard coronary distribution to another territory by
hybrid imaging. In this respect, in 45/252 (18%) patients, hybrid imaging reassigned an entire perfusion defect to another
coronary territory, changing the final diagnosis in 42% of the cases. Hybrid imaging allowed non-invasive CAD rule-out in
41%, and rule-in in 24% of patients, with a negative and positive predictive value of 88% and 87%, respectively.
Conclusion In patients at intermediate risk of CAD, hybrid imaging allows non-invasive co-localization of myocardial perfusion de-
fects and subtending coronary arteries, impacting clinical decision-making in almost one every five subjects.
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Introduction
The risk of patients with stable coronary artery disease (CAD) varies
considerably based on the extent of anatomical involvement and of
myocardial ischaemia.1 Unfortunately, there is disagreement between
the angiographic severity of CAD and myocardial perfusion abnor-
malities.2,3 Thus, current guidelines recommend a comprehensive
anatomo-functional assessment to decide on the most appropriate
treatment, with patients at low-risk treated conservatively, while high-
risk patients are generally referred for more aggressive therapies.1
Specifically, revascularization strategies should be guided by the pres-
ence of haemodynamically significant coronary stenosis, while non-
significant coronary stenoses may be treated conservatively.4,5
Recently, hybrid cardiac imaging has emerged as a non-invasive
way of assessing CAD by integration of myocardial perfusion images
with individual coronary anatomy.6 Small studies have suggested su-
perior diagnostic accuracy compared with the separate imaging mo-
dalities,7 whereas others have reported incremental prognostic
value.8 While the technique is finding increasing acceptance in clin-
ical practice, questions remain over the clinical role of hybrid im-
aging. Furthermore, the impact of the technique has never been
tested in a multicentre, multi-device, real-world setting.
This study sought to assess the clinical role of hybrid cardiac im-
aging in a multicentre study using different equipment and practice,




The EVINCI (EValuation of INtegrated Cardiac Imaging for the Detec-
tion and Characterization of Ischaemic Heart Disease) study is a
‘European Commission 7th Framework Program for Research and
Innovation’-sponsored multimodality imaging project in 14 centres
from 9 European countries.9 The characteristics of the study population
have been already described in detail9 and are summarized in Table 1.
Briefly, between March 2009 and June 2012, patients with symptoms
suggestive of CAD and intermediate pre-test probability (20–
90%)10,11 underwent a study of coronary anatomy by computed tomog-
raphy coronary angiography (CTCA) and at least one coronary
functional imaging test by myocardial perfusion scintigraphy (MPS),
single-photon emission computed tomography (SPECT) or positron
emission tomography (PET), and/or wall motion imaging (stress echo-
cardiography or cardiac magnetic resonance), with the recommenda-
tion to perform invasive coronary angiography (ICA) with fractional
flow reserve (FFR) in intermediate lesions. Each patient was followed-up
for 30 days and the referral for coronary revascularization recorded.
Ethical approval was provided by each centre, and all subjects gave
written informed consent.
Image acquisition
Acquisition protocols were agreed on for each technique based on best
available clinical practice. Individual core-labs were responsible for harmon-
ization and quality control of imaging protocols. Details on imaging proce-
dures and protocols can be found in the EVINCI publication.9 All EVINCI
subjects in whom core-lab analyses of CTCA, MPS, and ICA were available
were selected for the present hybrid sub-study (Figure 1). Accordingly, pa-
tients submitted to wall motion imaging modalities were not included in the
analysis, because their format precludes formation of 3D hybrid data sets
with CTCA. No further exclusion criterion was considered.
Image fusion
MPS and CTCA data sets were transferred to a dedicated hybrid core-
lab blinded to clinical history and imaging findings (Cardiac Imaging, Uni-
versity Hospital Zurich, Switzerland). Image fusion of MPS and CTCA
data sets was performed on a dedicated workstation (Advantage Work-
station 4.4, GE Healthcare) using the CardIQ Fusion software package
(GE Healthcare) as previously described.12 In case of H2
15O-PET images,
parametric myocardial blood flow data sets, showing flows on a seg-
mental level, were generated based on quantitative analysis performed
using a commercially available software, PMOD 3.6 software package
(PMOD Technologies Ltd, Zurich, Switzerland).
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Hybrid analysis was performed using an optimized alignment tool,
allowing projection of the MPS image on the left ventricular epicardial
surface obtained from the CTCA, allowing a panoramic view of the
coronary artery tree projected onto the left ventricular myocardial
perfusion territories. In all patients, the image fusion procedure
(including image generation and reading) was performed by two inde-
pendent and blinded operators. Disagreement with regard to alloca-
tion of myocardial perfusion defects was resolved by consensus
reading.
Image interpretation and definitions
Image interpretation was performed in dedicated core-labs as follows.
Computed tomography coronary angiography
CTCA was assessed using a modified 16-segment system13 and consid-
ered abnormal if at least one coronary segment had a diameter stenosis
.50%. Significant left main stem stenoses were assigned to both left an-
terior descending (LAD) and left circumflex (LCX) coronary arteries.
To limit any selection bias, any non-diagnostic segment was considered
abnormal.
Myocardial perfusion scintigraphy
Perfusion in each of 17 segments14 was visually classified as 0 ¼ normal,
1 ¼ mild reduction, 2 ¼ moderate reduction, 3 ¼ severe reduction, or
4 ¼ absent perfusion, and the segmental scores were summed for the
stress (SSS) and rest (SRS) images. 15O-H2O PET data were processed
and parametric perfusion images were scored similarly. The difference
between SSS and SRS was calculated as the summed difference score
(SDS). On per-patient analysis, a reversible perfusion defect (ischaemia)
was defined as a SDS ≥2, either from a score ≥1 in at least two
contiguous segments or ≥2 in at least one segment. Myocardial scar
was defined similarly as a SRS ≥2. Accordingly, MPS studies were con-
sidered pathological in the presence of significant myocardial ischaemia
and/or scar.
For per-vessel analysis, a reversible perfusion defect (ischaemia) was
defined as a territorial difference score ≥1, and a scar as a rest score
≥1. Each perfusion defect was assigned to one or more coronary terri-
tories according to the standardized myocardial segmentation model.14
Similarly to CTCA analysis, any non-diagnostic segment was considered
abnormal.
Invasive coronary angiography
Coronary angiograms were subdivided using the previously mentioned
segmentation model13 and analysed using quantitative coronary angiog-
raphy (QCA). A stenosis was considered haemodynamically significant if
causing a .50% diameter reduction in the left main stem or .70%
elsewhere, or between 30 and 70% with an FFR ≤0.80.
Hybrid images
All hybrid MPS/CTCA images were analysed by consensus of two inde-
pendent readers with regard to the presence of matched, mismatched,
or normal findings. A matched finding was defined as a perfusion defect
in a territory subtended by a stenotic coronary. All other combinations
of pathological findings were classified as mismatched. In the absence of
Figure 1 Patient flow chart. CTCA, coronary CT angiography;
ICA, invasive coronary angiography; FFR, fractional flow reserve;
MPS, myocardial perfusion imaging.
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Age, years (mean+ SD) 61+9
Male gender 161 (64)
Clinical characteristics, n (%)
Typical angina 62 (25)
Atypical angina 148 (59)
Non-anginal chest pain 42 (17)
Pre-test probability of CAD 59+23
Left ventricular ejection fraction 59+9
Cardiovascular risk factors, n (%)
Family history of CAD 75 (30)





Invasive coronary angiography data, n (%)
Normal coronaries or non-obstructive CAD 158 (63)
Single-vessel disease 60 (23)
Multi-vessel disease 34 (14)
Myocardial perfusion imaging, n (%)
Single-photon emission computed tomography 180 (71)
99mTc-Sestamibi 103 (57)
99mTc-Tetrofosmin 77 (43)




Data are given in absolute numbers and percentages (%), unless otherwise stated.
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pathological findings on both CTCA and MPS, hybrid images were con-
sidered normal. Finally, all pathological MPS segments were assigned to
the pertinent vascular territory by spatial co-registration according to
individual coronary anatomy by both operators to determine inter-
observer agreement and repeatability of hybrid-based co-registration.
Statistical analysis
Statistical analysis was performed using the SPSS software. Continuous
variables were expressed as mean+ SD, and categorical variables
as percentages. Numerical values were compared using the Mann–
Whitney U test or Student’s t-test, and categorical values using the
x2 test. Inter-observer agreement was assessed using Cohen’s kappa
statistic. Sensitivity, specificity, and accuracy were calculated for each
imaging method (MPS, CTCA, and hybrid imaging) on a per-vessel
and per-patient basis. The McNemar test was performed to compare
the accuracy of the different imaging methods against QCA+ FFR.
A value of P , 0.05 was considered significant.
Results
Patient population
A total of 252 patients underwent CTCA, MPS, and ICA and were
included in the analysis (Figure 1). The characteristics of the study
populations are shown in Table 1. Compared with the overall EVIN-
CI population,9 there were no significant differences in baseline
characteristics except for a slightly higher CAD prevalence in our
patient population (37 vs. 30%, P ¼ 0.05) (Supplementary data
online, Table SA).
Interestingly, as in the case of the main EVINCI population, also
in the present study, traditional criteria for calculating pre-test
probability11 overestimated the prevalence of haemodynamically
significant CAD, which was 37% at QCA+ FFR. FFR was performed
in 58/252 patients (23% of all patients and 66% of patients with
intermediate coronary stenoses) and was abnormal (≤0.80) in
19 patients.
Imaging results: MPS and CTCA
A total of 180 (71%) patients were submitted to SPECT while 72
(29%) underwent PET (Table 2). Overall, 104 (41%) patients pre-
sented myocardial perfusion abnormalities in one (8%), two
(41%), or three (51%) vascular territories. At core-lab analysis,
MPS images were judged of non-diagnostic quality (having at least
one non-diagnostic segment) in 11 patients.
On CTCA, 111 (44%) patients presented significant CAD in one
(48/111, 43%), two (41/111, 37%), or three (22/111, 20%) vessels
(Table 2) with no significant difference between patients submitted
to SPECT or PET. At core-lab analysis, CT images were judged of
non-diagnostic quality (having at least one non-diagnostic segment)
in 8 patients.
Hybrid imaging: feasibility and
repeatability
In 18/270 (7%) patients originally submitted to CTCA and MPS, hy-
brid imaging could not be accomplished due to corruption of origin-
al data sets (8 patients) or software incompatibility (10 patients).
Inter-rater agreement of hybrid-based co-registration was good
(k ¼ 0.75, 95% CI 0.70–0.80) with both observers agreeing in the
classification of 92% of all pathological myocardial segments.
Hybrid imaging: segment reclassification
A total of 4284 myocardial segments were analysed, of which 1004
(23%) were pathological. According to the standard myocardial seg-
mentation model, 397 (39%), 269 (27%), and 338 (34%) abnormal
segments were allocated to the LAD, LCX, and right coronary ar-
tery (RCA) vascular territory, respectively. After image fusion,
246 (25%) of the 1004 abnormal myocardial segments were
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Myocardial perfusion imaging data
Normal perfusion 148 (59) 111 (62) 37 (58) 0.175
Scar 41 (16) 35 (19) 6 (8) 0.037
Inducible ischaemia 88 (35) 54 (30) 34 (47) 0.013
Computed tomography data 0.599
One-vessel disease 48 (19) 38 (21) 10 (14)
Two-vessel disease 41 (16) 29 (16) 12 (17)
Three-vessel disease 22 (9) 15 (8) 7 (10)
Hybrid imaging 0.054
Hybrid match 61 (24) 39 (22) 22 (31)
Hybrid mismatch 88 (35) 68 (38) 20 (28)
MPS positive and CT negative 39 (15) 26 (14) 13 (18)
MPS negative and CT positive 49 (19) 42 (23) 7 (10)
Normal hybrid 103 (41) 73 (41) 30 (42)
Data are given as numbers and percentages, n (%).
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reclassified from their standard coronary distribution to another
territory (Table 3). Segment reclassification was highest for the
standard LCX (49%) and RCA (32%) segments, while it was very
low for standard LAD segments (2%; P , 0.001 vs. both LCX and
RCA). Figure 2 shows the proportion of pathological segments reas-
signed by hybrid imaging.
In 45/252 (18%) patients, hybrid imaging reassigned an entire per-
fusion defect to another coronary territory, changing the final diag-
nosis in 19 cases (from a mismatched to a matched finding in 16
patients, and the opposite in 3). Interestingly, in 16 (84%) of those
patients, the myocardial perfusion abnormality was correctly as-
signed to a territory subtended by a haemodynamically significant
stenosis at QCA+ FFR. The role of hybrid analysis in the anatomo-
functional characterization of patients and in identifying significant
CAD is exemplified in Figure 3.
‘Rule-in/rule-out’ clinical algorithm
The diagnostic accuracy of hybrid imaging and of stand-alone
imaging modalities in detecting significant CAD (QCA+ FFR) is
reported in Figure 4.
Specifically, a matched finding at hybrid imaging was found in 61
patients (24%), while 103 patients (41%) had normal hybrid findings.
Of the remaining 88 patients with mismatched abnormal findings
(35%), 45 presented a positive CTCA in the absence of perfusion
abnormalities at MPS, while 39 showed a pathological MPS despite
the absence of obstructive CAD at CTCA. Revascularization rates
were 70% for matched hybrid images, 36% for mismatched findings,
and 10% for normal findings (P , 0.001) (Figure 5).
Interestingly, among the 41 ‘false-negative’ hybrid studies (either
normal or mismatched findings in the presence of significant CAD
at QCA), the majority (80%) showed negative MPSs, despite a sten-
otic vessels on CTCA in 64% of the cases. FFR was performed in 17/
41 patients and was positive in 13 (76%) (Supplementary data online,
Table SB). On the other hand, the ‘false-positive’ hybrid studies were
almost exclusively associated with the presence of intermediate cor-
onary lesions (.30 and ≤70%) on QCA mainly in the absence of an
invasive assessment of the haemodynamic relevance of stenoses by
FFR (Supplementary data online, Table SC).
Radiation burden of the non-invasive
imaging protocol
Average radiation doses in the study population were 7.9 mSv (range
0.6–24 mSv) for CTCA, 10.4 mSv (range 3.2–17.5 mSv) for SPECT,
and 1.8 mSv (range 1.7–3.5 mSv) for PET. The average radiation dose
of hybrid imaging was 9.4 mSv (range 5.2–21 mSv) for PET/CTCA
and 18.5 mSv (range 6–31 mSv) for SPECT/CTCA (P , 0.001).
Discussion
The EVINCI hybrid sub-study is one of the largest studies to assess
the clinical value of non-invasive hybrid imaging in stable CAD. Sev-
eral methodological advantages, including the use of dedicated
blinded core-lab image analysis, the multicentre and multivendor de-
sign, and the use of an accepted invasive gold standard (QCA+
FFR), distinguish it from previously published reports and provide
greater uniformity and generalizability of its results. The main find-
ings of the study are (i) large variability of coronary anatomy leading
to systematic errors of standardized myocardial segmentation in
predicting culprit coronary vessels; (ii) hybrid imaging (by 3D
co-registration of CTCA and MPS) is feasible and reproducible;
and (iii) a hybrid anatomo-functional protocol allows non-invasive
‘rule-in/rule-out’ of haemodynamically significant CAD.
Standardized myocardial segmentation models are widely used to
assign myocardial territories to subtending coronary arteries.14
However, coronary anatomy is highly variable, which may frequently
lead to mistaken identification of culprit vessels by standard models.
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LAD Segment 1 50 0 (0) – 0 (0) 0 (0)
Segment 2 51 1 (2) – 0 (0) 1 (100)
Segment 7 56 0 (0) – 0 (0) 0 (0)
Segment 8 48 0 (0) – 0 (0) 0 (0)
Segment 13 62 0 (0) – 0 (0) 0 (0)
Segment 14 51 1 (2) – 0 (0) 1 (100)
Segment 17 79 6 (8) – 2 (33) 4 (67)
LCX Segment 5 72 25 (35) 0 (0) – 25 (100)
Segment 6 43 20 (47) 19 (95) – 1 (5)
Segment 11 58 20 (34) 17 (85) – 3 (15)
Segment 12 44 31 (70) 30 (97) – 1 (3)
Segment 16 52 35 (67) 30 (86) – 5 (14)
RCA Segment 3 55 13 (24) 10 (77) 3 (23) –
Segment 4 82 15 (18) 0 (0) 15 (100) –
Segment 9 52 15 (29) 12 (80) 3 (20) –
Segment 10 76 15 (20) 0 (0) 15 (100) –
Segment 15 73 49 (67) 42 (86) 7 (14) –
LV, left ventricle; LAD, left anterior descending artery; LCX, left circumflex artery; RCA, right coronary artery.
aFor exact location of perfusion segment within the LV see Figure 2A.
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In this respect, it has been previously suggested that hybrid imaging
may help in the individual co-localization of myocardial perfusion
abnormalities and subtending coronary arteries.15–18
We identified systematic deviation from the standardized assign-
ment of myocardial segments in 25% of pathological segments, loca-
lized almost exclusively in the standard LCX and RCA territories (i.e.
the lateral and inferior myocardial wall). This turned out to be clinic-
ally significant in almost every fifth patient, in whom the entire perfu-
sion defect was reassigned to another coronary artery, changing the
final diagnosis in almost half of them. This result might be of particular
relevance in patients considered for revascularization, where only
haemodynamically significant lesions deserve treatment.5,19
Previous reports have shown the feasibility and reproducibility of
3D fusion of anatomical (CTCA) and functional (MPS) imaging.12 In
this study, hybrid analysis was successfully performed in 93% of the
EVINCI patients originally submitted to MPS and CTCA with good
inter-observer repeatability, highlighting the robustness of the tech-
nique. In fact, technical image fusion failure occurred in only 7% of
patients mainly in the case of early generation SPECT devices with
incomplete or corrupted data sets or software incompatibility.
Given the heterogeneity of hybrid results (combining various
anatomo-functional patterns), we considered that a binary
diagnostic approach disregards the complexity of CAD. Conversely,
a ‘rule-in/rule-out’ hybrid-based approach appears more clinically
meaningful, since matched positive findings allow rule-in of CAD
and matched normal findings CAD rule-out (Figure 5). Accordingly,
although in the EVINCI study the clinical management of patients,
including the decision for coronary revascularization, was entirely
left to the judgement of the local clinician, possibly introducing a
bias in the analysis of the data, a matched positive hybrid finding
was still associated with a high early revascularization rate (70%).
On the other hand, in patients with a completely negative hybrid re-
port, the revascularization rate was extremely low (≈10%), making
ICA theoretically superfluous. It should be emphasized that the ma-
jority of false-negative hybrid studies were due to negative MPS
downstream of a stenotic coronary vessel at CTCA, which was con-
firmed by a .70% lumen diameter reduction at QCA (considered
as haemodynamically significant). After the FAME study,2 published
almost at the end of the EVINCI study, coronary stenoses between
70 and 90% should also be submitted to FFR since a considerable
proportion of these lesions have a normal FFR. On the other
hand, the false-positive hybrid imaging studies were essentially asso-
ciated with the presence of intermediate coronary lesions (.30 and
≤70%) that did not undergo an invasive evaluation of their
Figure 2 (A) Standardized myocardial segmentation model used in this study with number codes for each segment (see Table 3).14 (B) Reassign-
ment rates by hybrid imaging for the 1004 pathological segments (the intensity of colours in each segment indicates the frequency of reassignment of
that segment when pathological). (C) Pie chart indicating proportion of reassignment and reassignment fate for pathological segments in each stand-
ard coronary territory. Shades of red indicate standard LAD, of green standard LCX, and of blue standard RCA territories. Standard LCX segments
were most often reassigned to LAD (36%), while standard RCA segments were equally distributed between LAD and LCX.
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haemodynamic relevance through FFR and, thus, considered as not
significant. It is conceivable that, if FFR would have been more ex-
tensively performed, the number of ‘false-negative’ and ‘false-
positive’ results could have been considerably reduced. Interesting-
ly, a consistent proportion of those patients were still submitted to
coronary revascularization despite the absence of an objective
proof of myocardial ischaemia (either by MPS or through FFR) (Sup-
plementary data online, Tables SB and SC), further highlighting the
existing gap between evidence-based patient management1,3,5,19
and everyday clinical conduct.20
Patients with mismatched findings (positive MPS/negative CTCA
or negative MPS/positive CTCA) represent a heterogeneous group.
Figure 3 A 55-year-old gentleman with atypical chest pain. (A) SPECT shows a reversible perfusion defect inferiorly with lateral extension, and
in addition, there is a separate reversible perfusion defect involving the apical region and the mid-ventricular anteroseptal wall. (B) The perfusion
polar maps show the SPECT core-lab interpretation (white ¼ normal, yellow ¼ mildly reduced, orange ¼ moderately reduced, and red ¼
severely reduced radiotracer uptake) with pathological segments assigned to all three coronary territories. (C ) CTCA reveals two 70–90%
mid LAD stenoses, a 50% proximal LCX stenosis, and a probable occlusion of the mid RCA (arrows). (D) On hybrid imaging, the entire infero-
lateral perfusion defect is reassigned to the RCA, effectively changing the diagnosis from three-vessel to two-vessel disease. (E) Imaging findings
were confirmed on QCA showing two high-grade lesions in the mid LAD, diffuse non-significant disease in the LCX, and a chronic total occlusion
of the mid RCA.
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In the absence of coronary stenoses on CTCA, myocardial perfu-
sion defects may represent either artefacts or microvascular/endo-
thelial dysfunction. Accordingly, in this group, CAD prevalence and
revascularization rates were low (Figure 5). CTCA has a very high
negative predictive value as demonstrated by a vast number of stud-
ies comparing it with the angiographical gold standard of ICA.21 The
fact that we used a more comprehensive anatomo-functional gold
standard (ICA + FFR) may explain to some extent the low sensitiv-
ity. Moreover, the sensitivity of CTCA by core-lab analysis in the
main EVINCI trial was lower than by individual-centre analysis.9
As a result, some lesions may have been underestimated accounting
for the small number of revascularizations in this group.
Conversely, patients with significant coronary stenoses on CTCA
but the absence of perfusion defects had a substantial CAD preva-
lence and revascularization rate (40 and 42%, respectively). This
finding has several explanations. On one hand, the gold standard
used in the present study was mainly anatomical (QCA), favouring
agreement with CTCA rather than MPS. On the other hand, as al-
ready shown,22 the cut-off chosen for FFR (≤0.80)5,19 may overesti-
mate the haemodynamic significance of CAD compared with
Figure 4 Accuracy analysis of stand-alone and hybrid protocols for the diagnosis of significant CAD (by QCA+ FFR) on per-vessel (A) and
per-patient (B) analysis. On a per-vessel basis, when positivity was defined by the presence of at least one positive test (either matched or mis-
matched findings), hybrid imaging had higher sensitivity than single modalities (P , 0.001 vs. MPS and CTCA), at the price of lower specificity
(P , 0.001 vs. both MPS and CTCA) and accuracy (P , 0.001 vs. both MPS and CTCA). When only matched findings were considered positive,
hybrid imaging increased accuracy (P , 0.001 vs. both MPS and CTCA) driven by higher specificity (P , 0.001 vs. both MPS and CTCA) but with
lower sensitivity (P , 0.001 vs. MPS and CTCA).
Figure 5 Hybrid-based ‘rule-in/rule-out’ clinical protocol.
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non-invasive ischaemia testing. In line with this evidence, among the
19 patients with a pathological FFR evidenced in this study, only 21%
had a matched finding on hybrid imaging. Interestingly, only 12/19
(63%) of those lesions presented a FFR ≤0.75, as a more stringent
cut-off for positivity.3 However, the incomplete FFR penetration ob-
served in the present study, mainly due to protocol violations, does
not allow defining whether the use of a lower cut-off value of FFR
would have better correlated with hybrid findings.
Such a ‘rule-in/rule-out’ protocol is supported by follow-up data,
indicating low event rates in patients with normal hybrid findings,
high event rates for pathological matched findings, and intermediate
event rates with mismatched findings.8 Moreover, in selected cases,
our integrated protocol may overcome the limitations of the more
simplistic binary (i.e. either functional or anatomic) approach usually
applied to CAD diagnostics, as recently reported.23
Limitations
Like the overall EVINCI population, our study had a significant drop-
out rate, as not every patient underwent all protocol-specified im-
aging studies. Additionally, data corruption and incomplete data sets
accounted for further dropouts. Accordingly, 252 of the 697 pa-
tients originally enrolled in the EVINCI study were included in the
present sub-study. However, those represented all the EVINCI
patients that underwent MPS, CTCA, and ICA and in whom, thus,
hybrid analysis could be practically performed. In fact, only a margin-
al portion of those patients (7%) was excluded because of technical
reasons, confirming the overall robustness of 3D image fusion.
Moreover, since the demographical, clinical, and angiographic char-
acteristics of the present patients were almost superimposable to
those of the main EVINCI population,9 the presence of a significant
selection bias can be excluded (Supplementary data online,
Table SA). Second, no long-term follow-up data were obtained pre-
cluding any analysis on the impact of hybrid imaging on downstream
patient management and outcomes. Third, FFR rate was only 23%,
and 34% of patients with intermediate lesions were not interrogated
with FFR. Incomplete FFR penetration due to frequent protocol vio-
lations highlights the sub-optimal FFR use across Europe and may
have been responsible for some of the ‘false-negative’ hybrid findings
and prevents any conclusive analysis on the ‘false-positive’ studies
(Supplementary data online, Tables SB and SC). In our study, the re-
spective sensitivities of CTCA and MPS were lower than anticipated
from small single-centre studies (particularly for CTCA: 78%). This
may be explained by selecting higher risk patients who had additional
MPS performed, as well as by the inclusion of patients with intermedi-
ate stenosis (30–70%) without invasive functional evaluation, and by
the exclusive use of independent core-lab data for the present ana-
lysis. In fact, the accuracies of stand-alone imaging modalities reported
were almost superimposable to those of the overall EVINCI study
when only core-lab data were considered.9 Notably, on centre-based
analysis, the diagnostic accuracy of the different non-invasive imaging
modalities was generally improved compared with the core-lab data.
Nevertheless, even when only individual-centre data were consid-
ered, hybrid imaging maintained significantly elevated specificity and
overall diagnostic accuracy, at both per-patient and vessel-based
analyses (Supplementary data online, Figure S1).
Moreover, in the accuracy analyses, MPS was considered patho-
logical in the presence of ischaemia and/or scar. Interestingly, the
presence of a matched hybrid finding showed comparable sensitiv-
ity, specificity, and accuracy if myocardial ischaemia (and not scar)
was considered as the only positivity criteria (50, 96, and 79%,
respectively).
Finally, the added radiation exposure from hybrid protocols must
also be considered. In the present study, average radiation doses
varied considerably, depending on the imaging technique (PET vs.
SPECT) and on the acquisition protocol employed. Specifically,
the theoretical risk related to the radiation exposure of a SPECT/
CTCA hybrid protocol may appear rather high, particularly if com-
pared with PET/CTCA imaging or other non-invasive imaging
modalities.24 However, previous results suggest that the use of
modern equipment and dose-optimization protocols (e.g. prospect-
ive ECG-triggering for CTCA, stress-only for SPECT) may consist-
ently reduce the radiation burden of hybrid imaging,25 favouring its
clinical application on a larger scale. Nevertheless, further long-term
comparative studies are probably needed to conclusively define the
cost-efficiency and quantitate the added radiation hazard that may
be related to hybrid imaging, and to definitively assess its possible
prognostic impact.
Conclusions
Hybrid imaging allows more reliable co-localization of myocardial
perfusion defects with subtending coronary arteries than standar-
dized myocardial segmentation models accounting for variations
in individual coronary anatomy. In two-thirds of patients at inter-
mediate pre-test probability of CAD, hybrid imaging may offer a
non-invasive ‘rule-in/rule-out’ of patients with haemodynamically
significant CAD.
Supplementary data
Supplementary data are available at European Heart Journal – Cardio-
vascular Imaging online.
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Detection of significant coronary artery disease by noninvasive anatomical and
functional imaging. Circ Cardiovasc Imaging 2015;8:pii:e002179. doi:11.1161/
CIRCIMAGING.114.002179.
10. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis
of coronary-artery disease. N Engl J Med 1979;300:1350–8.
11. Fox K, Garcia MA, Ardissino D, Buszman P, Camici PG, Crea F et al. Guidelines on
the management of stable angina pectoris: full text. The Task Force on the Manage-
ment of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J
2006;27:1341–81.
12. Gaemperli O, Schepis T, Kalff V, Namdar M, Valenta I, Stefani L et al. Validation of a
new cardiac image fusion software for three-dimensional integration of myocardial
perfusion SPECT and stand-alone 64-slice CT angiography. Eur J Nucl Med Mol Im-
aging 2007;34:1097–106.
13. Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS et al. A report-
ing system on patients evaluated for coronary artery disease. Report of the Ad Hoc
Committee for Grading of Coronary Artery Disease, Council on Cardiovascular
Surgery, American Heart Association. Circulation 1975;51:5–40.
14. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK et al. Stan-
dardized myocardial segmentation and nomenclature for tomographic imaging of
the heart. A statement for healthcare professionals from the Cardiac Imaging
Committee of the Council on Clinical Cardiology of the American Heart Associ-
ation. Circulation 2002;105:539–42.
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